[On the intrapleural and intrabronchial administration of morphazinamide administered alone and in association with dexamethasone 21-orthophosphate].
D000336:Aerosols; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D004654:Empyema, Tuberculous / Q000188:drug therapy*; D006801:Humans; D011719:Pyrazines / Q000008:administration & dosage / Q000627:therapeutic use; D012996:Solutions; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000336:Aerosols; D000995:Antitubercular Agents; D011719:Pyrazines; D012996:Solutions; D003907:Dexamethasone
Sull'impiego per via endopleurica e per via endobronchiale della morfazinamide somministrata da sola ed in associazione col desametazone 21-ortofosfato.